IMMU-41. HIGH-THROUGHPUT RETRIEVAL OF THERAPEUTIC T CELL RECEPTORS FROM GLIOMA

Gliomas are tumors with low mutational burden with the majority of them being resistant to checkpoint inhibition due to few immunogenic antigens. Multicenter vaccine trials targeting personalized neoantigens in gliomas demonstrated feasibility and illustrated the challenges of retrieving neoepitope-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Lindner, Katharina, Tan, Chin Leng, Bozza, Matthias, Sanghvi, Khwab, Poschke, Isabel, Harbottle, Richard, von Deimling, Andreas, Wick, Wolfgang, Sahm, Felix, Platten, Michael, Green, Edward W, Bunse, Lukas
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650922/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.471
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados